Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Comparative genomic hybridization (CGH) using 40 cell lines derived from malignant melanomas (MMs) revealed frequent amplification at 7q33-q34 containing BRAF gene, which often is mutated in MM. We found this gene to be amplified to a remarkable degree in the MM cell lines that exhibited high-level gains at 7q33-q34 in CGH. Among 40 cell lines, the eight lines that revealed neither BRAF nor NRAS mutations showed even higher levels of BRAF mRNA expression than the 32 mutated lines, although DNA amplification at 7q33-q34 was not detected in every lines overexpressing BRAF. MM cells that carried wild-type BRAF and NRAS showed constitutive overexpression of B-Raf protein and phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), even after serum starvation. Not only downregulation of the endogenously overexpressed wild-type B-Raf by antisense oligonucleotide but also a treatment with an inhibitor of mitogen-activated protein kinase kinase (MAPKK, MEK) reduced phosphorylated ERK1/2 and cell growth, whereas the exogenously expressed wild-type B-Raf promoted cell growth in MM cells. Our results provide the evidence that overexpression of wild-type B-Raf, in part but not always as a result of gene amplification, is one of the mechanisms underlying constitutive activation of the MAPK pathway that stimulates growth of MM cells.
Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Hideaki
H
Tanami
Issei
I
Imoto
Akira
A
Hirasawa
Yasuhiro
Y
Yuki
Itaru
I
Sonoda
Jun
J
Inoue
Kohichiro
K
Yasui
Akiko
A
Misawa-Furihata
Yutaka
Y
Kawakami
Johji
J
Inazawa
D015153:Blotting, Western; D002455:Cell Division / Q000235:genetics*; D045744:Cell Line, Tumor; D002897:Chromosomes, Human, Pair 7; D011905:Genes, ras; D006801:Humans; D008545:Melanoma / Q000201:enzymology / Q000235:genetics / Q000473:pathology*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009154:Mutation; D009693:Nucleic Acid Hybridization; D010766:Phosphorylation; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012878:Skin Neoplasms / Q000201:enzymology / Q000235:genetics / Q000473:pathology*
D012333:RNA, Messenger; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D020928:Mitogen-Activated Protein Kinases